Medtech & Digital Therapeutics

Medtech & Digital Therapeutics

Dark abstract geometric shapes creating a layered pattern with gradient shading.

The next generation of digital therapeutics is changing how disease is prevented, managed, and treated but also raising new challenges around ownership, regulation, and data. In this high-growth space, our experts help you protect your innovation and maximise the return on your intellectual property (IP).

Digital therapeutics are offering pharma companies new ways to increase the impact of treatments and reduce patients' reliance on local healthcare services. To capitalise on this, many are partnering with tech businesses to access a market predicted to reach $19 billion by 2030.

But increased collaboration brings increased risk. Who owns the IP? How will health data be used and protected? What are the regulatory implications, and who is responsible?

To deliver value and reduce risk, these partnerships need specialist IP support. You need advisers who understand both the pharmaceutical and technical elements of your product, and who know how best to protect, leverage, and deliver both to maximise commercial return.

Contact our medtech and digital therapeutics team to discuss your innovation today.

How We Help Protect and Commercialise Your Digital Health Innovation

Bringing a digital health venture to market means combining different areas of expertise to create something viable and commercially valuable. Whether you're the pharmaceutical partner or the tech partner, you need trusted advisors who understand both domains and how to protect their value.

You'll work with patent attorneys and IP solicitors who have advised on many digital health projects. Our team includes experts in disease, treatment, pharmacology, and the regulatory environment, as well as specialists in software, data management, and analytics. This ensures your innovation is fully supported from both a clinical and technical perspective.

Based on our experience, these are the issues that need to be addressed from the outset:

  • Define who owns what and how all parties will be remunerated from the outset.
  • Clarify data ownership and usage.
  • Create a business model that enables each partner to maximise returns from all potential revenue sources.
  • Plan for scalability so your partnership can meet growing demand.
  • Limit the number of partnerships to avoid making progress difficult to manage.
  • Keep patients' and clinicians' needs front and centre.

A Seamless Multidisciplinary Team

Our multidisciplinary team is different from most firms in that our patent attorneys and IP solicitors work closely together. This guarantees you receive the complete range of IP and legal support you need to protect your IP and create the highest level of value from your digital therapeutics venture.

  • Our patent attorneys will identify all the innovations present and construct the IP strategy you need to deliver your business plan. This will be approached from both a pharmaceutical and technology point of view, so that both your software and clinical innovation are fully protected.
  • Our solicitors specialise in drafting and negotiating domestic and multi-jurisdictional agreements. They work with numerous clients in the medtech and digital therapeutics space and will ensure all necessary commercial arrangements are in place to execute your business plan.
  • If your position or IP is challenged, our experienced litigators will guide you through the process within the UK, Europe and, if required, internationally.
  • Our trade mark attorneys will protect your brand and alert you to any unauthorised or unwelcome attention from your competitors.

Related News

Innovating Intellectual Property: Spotlight on Dave Clark, Partner at Potter Clarkson

Innovating Intellectual Property: Spotlight on Dave Clark, Partner at Potter Clarkson

How healthcare companies can comply with the EU AI Act and avoid heavy penalties

How healthcare companies can comply with the EU AI Act and avoid heavy penalties

Proteotype Diagnostics awarded £1.5 million Cancer Mission Grant to advance early cancer detection with innovative Enlighten™ test

Proteotype Diagnostics awarded £1.5 million Cancer Mission Grant to advance early cancer detection with innovative Enlighten™ test

Femtech and AI: Data is king

Femtech and AI: Data is king

Court of Appeal confirms that UPC has no jurisdiction over Ireland (at least not yet)

Court of Appeal confirms that UPC has no jurisdiction over Ireland (at least not yet)

Wave of substantive decisions by UPC in early revocation and infringement actions

Wave of substantive decisions by UPC in early revocation and infringement actions

Using IP to attract investors in a FemTech company

Using IP to attract investors in a FemTech company

Technology spotlight: Smart rings

Technology spotlight: Smart rings

Get in Touch with Our Medtech & Digital Therapeutics Team

Dave Clark
Peter Finnie
Dan Hudson
Oliver Laing
Fiona Law

Want to discuss how we can support your next medtech or digital therapeutics innovation? Fill in the form and we'll be in touch soon.

Thank you.
Your details have been submitted.
Oops! Something went wrong while submitting the form.